Liao Fu-Jun, Zheng Peng-Fei, Guan Yao-Zong, Pan Hong-Wei, Li Wei
Department of Cardiology, Affiliated Hospital of Guizhou Medical University, 28 Guiyi Street, Guiyang, 550002, Guizhou, People's Republic of China.
Department of Cardiology, The Central Hospital of ShaoYang, 36 QianYuan lane, Shaoyang, 422000, Hunan, People's Republic of China.
Nutr Metab (Lond). 2021 Mar 4;18(1):24. doi: 10.1186/s12986-021-00555-2.
The purpose of this study was to explore the potential molecular targets of hyperlipidaemia and the related molecular mechanisms.
The microarray dataset of GSE66676 obtained from patients with hyperlipidaemia was downloaded. Weighted gene co-expression network (WGCNA) analysis was used to analyse the gene expression profile, and the royal blue module was considered to have the highest correlation. Gene Ontology (GO) functional and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were implemented for the identification of genes in the royal blue module using the Database for Annotation, Visualization and Integrated Discovery (DAVID) online tool (version 6.8; http://david.abcc.ncifcrf.gov ). A protein-protein interaction (PPI) network was established by using the online STRING tool. Then, several hub genes were identified by the MCODE and cytoHubba plug-ins in Cytoscape software.
The significant module (royal blue) identified was associated with TC, TG and non-HDL-C. GO and KEGG enrichment analyses revealed that the genes in the royal blue module were associated with carbon metabolism, steroid biosynthesis, fatty acid metabolism and biosynthesis pathways of unsaturated fatty acids. SQLE (degree = 17) was revealed as a key molecule associated with hypercholesterolaemia (HCH), and SCD was revealed as a key molecule associated with hypertriglyceridaemia (HTG). RT-qPCR analysis also confirmed the above results based on our HCH/HTG samples.
SQLE and SCD are related to hyperlipidaemia, and SQLE/SCD may be new targets for cholesterol-lowering or triglyceride-lowering therapy, respectively.
本研究旨在探索高脂血症的潜在分子靶点及相关分子机制。
下载从高脂血症患者获得的GSE66676基因芯片数据集。采用加权基因共表达网络(WGCNA)分析来分析基因表达谱,认为皇家蓝模块具有最高相关性。使用注释、可视化和综合发现数据库(DAVID)在线工具(版本6.8;http://david.abcc.ncifcrf.gov)对皇家蓝模块中的基因进行基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路富集分析。通过在线STRING工具建立蛋白质-蛋白质相互作用(PPI)网络。然后,在Cytoscape软件中使用MCODE和cytoHubba插件鉴定了几个枢纽基因。
鉴定出的显著模块(皇家蓝)与总胆固醇(TC)、甘油三酯(TG)和非高密度脂蛋白胆固醇(non-HDL-C)相关。GO和KEGG富集分析显示,皇家蓝模块中的基因与碳代谢、类固醇生物合成、脂肪酸代谢以及不饱和脂肪酸生物合成途径有关。鲨烯环氧酶(SQLE,度 = 17)被揭示为与高胆固醇血症(HCH)相关的关键分子,硬脂酰辅酶A去饱和酶(SCD)被揭示为与高甘油三酯血症(HTG)相关的关键分子。基于我们的HCH/HTG样本,逆转录-定量聚合酶链反应(RT-qPCR)分析也证实了上述结果。
SQLE和SCD与高脂血症相关,且SQLE/SCD可能分别是降胆固醇或降甘油三酯治疗的新靶点。